Wp Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Wp Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$98.98 - $115.74 $19,796 - $23,148	-200 Reduced 7.69%	2,400 $277,000
Q2 2023 Jul 26, 2023	SELL	$96.34 - $112.38 $4,817 - $5,619	-50 Reduced 1.89%	2,600 $267,000
Q1 2023 Apr 14, 2023	SELL	$107.32 - $113.5 $16,097 - $17,025	-150 Reduced 5.36%	2,650 $289,000
Q4 2022 Jan 20, 2023	BUY	$62.39 - $113.8 $174,692 - $318,640	2,800 New	2,800 $0
Q2 2022 Jul 12, 2022	BUY	$79.4 - $116.36 $7,940 - $11,636	100 Added 3.45%	3,000 $239,000

Q1 2022 Apr 25, 2022	BUY	$86.42 - $109.81 $34,568 - $43,924	400 Added 16.0%	2,900 $305,000
Q4 2021 Feb 02, 2022	BUY	$98.56 - $119.91 $246,400 - $299,775	2,500 New	2,500 $269,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wp Advisors, LLC with notifications on news.